Which statement aligns with obesity management guidelines?

Which statement aligns with obesity management guidelines?

• A. Target a 5-10% initial body weight loss to improve risk factors.
• B. Pharmacotherapy should never be considered.
• C. Orlistat dosing is 60 mg three times daily with meals.
• D. Daily energy deficit should be greater than 1000 kcal.

Answer: (A)

Setting a realistic initial weight-loss target is crucial because modest losses produce meaningful health benefits and are achievable for many patients. A 5–10% reduction in body weight over several months consistently improves cardiometabolic risk factors, including blood pressure, triglycerides, HDL cholesterol, and fasting glucose, and it lowers the risk of developing type 2 diabetes and cardiovascular events. The other statements miss key guidelines: pharmacotherapy can be appropriate for certain individuals after lifestyle therapy, not forever ruled out; an energy deficit of 500–750 kcal per day is typically recommended rather than more than 1000 kcal; and while orlistat dosing exists (with products ranging between 60 mg and 120 mg per dose depending on the product), the important guideline point is the strategy and likelihood of benefit, not a single fixed dose.

Setting a realistic initial weight-loss target is crucial because modest losses produce meaningful health benefits and are achievable for many patients. A 5–10% reduction in body weight over several months consistently improves cardiometabolic risk factors, including blood pressure, triglycerides, HDL cholesterol, and fasting glucose, and it lowers the risk of developing type 2 diabetes and cardiovascular events. The other statements miss key guidelines: pharmacotherapy can be appropriate for certain individuals after lifestyle therapy, not forever ruled out; an energy deficit of 500–750 kcal per day is typically recommended rather than more than 1000 kcal; and while orlistat dosing exists (with products ranging between 60 mg and 120 mg per dose depending on the product), the important guideline point is the strategy and likelihood of benefit, not a single fixed dose.